Zhejiang Yatai Pharmaceutical Co Ltd
SZSE:002370
Income Statement
Earnings Waterfall
Zhejiang Yatai Pharmaceutical Co Ltd
Revenue
|
420.6m
CNY
|
Cost of Revenue
|
-288.5m
CNY
|
Gross Profit
|
132.1m
CNY
|
Operating Expenses
|
-165.9m
CNY
|
Operating Income
|
-33.8m
CNY
|
Other Expenses
|
22m
CNY
|
Net Income
|
-11.9m
CNY
|
Income Statement
Zhejiang Yatai Pharmaceutical Co Ltd
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
314
N/A
|
339
+8%
|
359
+6%
|
376
+5%
|
376
0%
|
372
-1%
|
380
+2%
|
397
+4%
|
463
+17%
|
575
+24%
|
691
+20%
|
758
+10%
|
863
+14%
|
903
+5%
|
930
+3%
|
1 094
+18%
|
1 083
-1%
|
1 156
+7%
|
1 251
+8%
|
1 217
-3%
|
1 310
+8%
|
1 357
+4%
|
1 222
-10%
|
1 076
-12%
|
709
-34%
|
492
-31%
|
393
-20%
|
345
-12%
|
515
+49%
|
445
-14%
|
409
-8%
|
372
-9%
|
315
-15%
|
304
-3%
|
324
+6%
|
331
+2%
|
373
+13%
|
663
+77%
|
667
+1%
|
675
+1%
|
421
-38%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(219)
|
(223)
|
(232)
|
(240)
|
(232)
|
(225)
|
(215)
|
(223)
|
(273)
|
(352)
|
(432)
|
(472)
|
(523)
|
(554)
|
(562)
|
(656)
|
(601)
|
(623)
|
(669)
|
(647)
|
(735)
|
(808)
|
(749)
|
(679)
|
(484)
|
(319)
|
(246)
|
(201)
|
(258)
|
(221)
|
(211)
|
(202)
|
(210)
|
(200)
|
(216)
|
(222)
|
(247)
|
(437)
|
(442)
|
(450)
|
(289)
|
|
Gross Profit |
95
N/A
|
116
+22%
|
126
+9%
|
136
+8%
|
144
+6%
|
147
+2%
|
165
+12%
|
175
+6%
|
190
+9%
|
224
+17%
|
259
+16%
|
286
+10%
|
340
+19%
|
350
+3%
|
369
+5%
|
438
+19%
|
483
+10%
|
533
+10%
|
581
+9%
|
571
-2%
|
575
+1%
|
549
-5%
|
473
-14%
|
397
-16%
|
225
-43%
|
172
-23%
|
148
-14%
|
144
-3%
|
257
+78%
|
224
-13%
|
198
-12%
|
171
-14%
|
105
-39%
|
104
-1%
|
109
+4%
|
109
+1%
|
126
+15%
|
225
+79%
|
225
0%
|
225
0%
|
132
-41%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(93)
|
(94)
|
(90)
|
(96)
|
(98)
|
(102)
|
(110)
|
(114)
|
(126)
|
(140)
|
(144)
|
(156)
|
(179)
|
(179)
|
(192)
|
(231)
|
(253)
|
(274)
|
(296)
|
(293)
|
(323)
|
(302)
|
(315)
|
(311)
|
(691)
|
(1 006)
|
(987)
|
(1 004)
|
(332)
|
(308)
|
(309)
|
(264)
|
(234)
|
(282)
|
(256)
|
(245)
|
(184)
|
(302)
|
(312)
|
(311)
|
(166)
|
|
Selling, General & Administrative |
(90)
|
(92)
|
(87)
|
(93)
|
(76)
|
(96)
|
(104)
|
(108)
|
(95)
|
(137)
|
(140)
|
(151)
|
(129)
|
(165)
|
(177)
|
(204)
|
(199)
|
(263)
|
(281)
|
(278)
|
(255)
|
(255)
|
(266)
|
(271)
|
(350)
|
(382)
|
(374)
|
(389)
|
(278)
|
(267)
|
(250)
|
(206)
|
(188)
|
(190)
|
(170)
|
(163)
|
(122)
|
(230)
|
(240)
|
(237)
|
(129)
|
|
Research & Development |
0
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(23)
|
0
|
0
|
0
|
(27)
|
0
|
0
|
(13)
|
(44)
|
0
|
0
|
(17)
|
(57)
|
(53)
|
(63)
|
(58)
|
(61)
|
(68)
|
(67)
|
(63)
|
(32)
|
(35)
|
(31)
|
(30)
|
(22)
|
(25)
|
(24)
|
(22)
|
(22)
|
(40)
|
(38)
|
(42)
|
(18)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
(21)
|
0
|
0
|
0
|
(39)
|
0
|
0
|
0
|
(27)
|
0
|
0
|
0
|
(25)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(19)
|
|
Other Operating Expenses |
(3)
|
(2)
|
(3)
|
(3)
|
(0)
|
(7)
|
(6)
|
(6)
|
(0)
|
(4)
|
(4)
|
(5)
|
(0)
|
(14)
|
(15)
|
(15)
|
8
|
(10)
|
(14)
|
0
|
10
|
5
|
14
|
19
|
(242)
|
(557)
|
(547)
|
(552)
|
5
|
(6)
|
(28)
|
(28)
|
2
|
(67)
|
(61)
|
(60)
|
(21)
|
(32)
|
(33)
|
(33)
|
0
|
|
Operating Income |
2
N/A
|
23
+1 150%
|
37
+64%
|
41
+10%
|
46
+13%
|
45
-2%
|
55
+22%
|
61
+12%
|
64
+5%
|
84
+31%
|
115
+38%
|
130
+13%
|
161
+24%
|
171
+6%
|
177
+4%
|
207
+17%
|
230
+11%
|
259
+13%
|
286
+10%
|
278
-3%
|
252
-9%
|
247
-2%
|
158
-36%
|
86
-45%
|
(466)
N/A
|
(833)
-79%
|
(839)
-1%
|
(861)
-3%
|
(76)
+91%
|
(84)
-11%
|
(111)
-32%
|
(93)
+16%
|
(129)
-38%
|
(178)
-38%
|
(147)
+17%
|
(135)
+8%
|
(58)
+57%
|
(77)
-32%
|
(87)
-13%
|
(86)
+0%
|
(34)
+61%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
4
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
2
|
(9)
|
(18)
|
(25)
|
(19)
|
(9)
|
1
|
9
|
6
|
2
|
(2)
|
(9)
|
(11)
|
(13)
|
(22)
|
(30)
|
(1 136)
|
(1 183)
|
(1 189)
|
(1 185)
|
(58)
|
(53)
|
(10)
|
(29)
|
(22)
|
(27)
|
(69)
|
(57)
|
(58)
|
(96)
|
(92)
|
(80)
|
(30)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(6)
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(319)
|
(0)
|
(0)
|
0
|
163
|
189
|
189
|
189
|
(72)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(0)
|
1
|
1
|
(1)
|
2
|
0
|
(0)
|
(0)
|
3
|
3
|
6
|
8
|
9
|
8
|
11
|
9
|
0
|
(1)
|
(6)
|
(6)
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
(23)
|
(23)
|
(23)
|
(1)
|
(25)
|
(24)
|
(24)
|
(9)
|
(19)
|
32
|
32
|
52
|
|
Pre-Tax Income |
6
N/A
|
28
+378%
|
42
+50%
|
43
+4%
|
48
+12%
|
49
+1%
|
58
+20%
|
66
+13%
|
66
+0%
|
78
+19%
|
104
+32%
|
112
+8%
|
144
+28%
|
171
+18%
|
189
+11%
|
225
+19%
|
237
+5%
|
260
+10%
|
277
+7%
|
263
-5%
|
241
-8%
|
234
-3%
|
136
-42%
|
56
-59%
|
(1 922)
N/A
|
(2 018)
-5%
|
(2 030)
-1%
|
(2 046)
-1%
|
28
N/A
|
29
+3%
|
45
+54%
|
43
-3%
|
(224)
N/A
|
(230)
-3%
|
(240)
-4%
|
(216)
+10%
|
(135)
+37%
|
(192)
-42%
|
(146)
+24%
|
(134)
+8%
|
(12)
+91%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(0)
|
(4)
|
(6)
|
(6)
|
(8)
|
(8)
|
(9)
|
(10)
|
(10)
|
(12)
|
(14)
|
(12)
|
(17)
|
(21)
|
(25)
|
(33)
|
(34)
|
(38)
|
(43)
|
(43)
|
(32)
|
(34)
|
(19)
|
(8)
|
0
|
0
|
14
|
11
|
(1)
|
0
|
(7)
|
(4)
|
(4)
|
(3)
|
4
|
2
|
3
|
4
|
3
|
2
|
(0)
|
|
Income from Continuing Operations |
5
|
24
|
36
|
37
|
41
|
41
|
50
|
56
|
57
|
67
|
90
|
100
|
127
|
150
|
164
|
192
|
203
|
222
|
234
|
220
|
209
|
200
|
117
|
48
|
(1 921)
|
(2 003)
|
(2 016)
|
(2 035)
|
27
|
28
|
38
|
39
|
(228)
|
(233)
|
(236)
|
(215)
|
(133)
|
(188)
|
(142)
|
(131)
|
(12)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
5
N/A
|
24
+344%
|
36
+49%
|
37
+5%
|
41
+9%
|
41
+1%
|
50
+21%
|
56
+13%
|
56
-1%
|
65
+17%
|
88
+35%
|
98
+11%
|
125
+28%
|
148
+18%
|
163
+10%
|
190
+17%
|
202
+6%
|
221
+9%
|
232
+5%
|
218
-6%
|
208
-5%
|
199
-4%
|
117
-41%
|
48
-59%
|
(1 921)
N/A
|
(2 002)
-4%
|
(2 015)
-1%
|
(2 035)
-1%
|
27
N/A
|
28
+3%
|
38
+34%
|
39
+4%
|
(228)
N/A
|
(233)
-2%
|
(236)
-1%
|
(215)
+9%
|
(133)
+38%
|
(188)
-42%
|
(142)
+24%
|
(131)
+8%
|
(12)
+91%
|
|
EPS (Diluted) |
0.01
N/A
|
0.05
+400%
|
0.08
+60%
|
0.08
N/A
|
0.1
+25%
|
0.1
N/A
|
0.12
+20%
|
0.14
+17%
|
0.14
N/A
|
0.16
+14%
|
0.22
+38%
|
0.18
-18%
|
0.28
+56%
|
0.27
-4%
|
0.32
+19%
|
0.34
+6%
|
0.38
+12%
|
0.41
+8%
|
0.43
+5%
|
0.41
-5%
|
0.39
-5%
|
0.38
-3%
|
0.23
-39%
|
0.1
-57%
|
-3.58
N/A
|
-3.73
-4%
|
-3.75
-1%
|
-3.79
-1%
|
0.05
N/A
|
0.06
+20%
|
0.07
+17%
|
0.07
N/A
|
-0.43
N/A
|
-0.4
+7%
|
-0.51
-28%
|
-0.36
+29%
|
-0.25
+31%
|
-0.35
-40%
|
-0.26
+26%
|
-0.21
+19%
|
-0.02
+90%
|